Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ZYME — Zymeworks Inc.

CIK 72971 SAN FRANCISCO, CA
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,677,581
+$929,098 QoQ
Shares Held
217,199
+14.5% QoQ
Ownership
0.306%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ZYME ranks #54 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,677,581 217,199
2026-03-31 $4,748,483 189,636
2025-12-31 $5,484,880 208,313
2025-09-30 $3,016,908 176,634
2025-06-30 $2,088,670 166,428
2025-03-31 $1,194,679 100,309
2024-12-31 $2,401,807 164,058
2024-09-30 $2,226,494 177,410
2024-06-30 $1,447,320 170,073
2024-03-31 $2,510,985 238,687
2023-12-31 $2,475,374 238,246
2023-09-30 $1,214,933 191,630
2023-06-30 $1,783,217 206,391
2023-03-31 $767,197 84,867
2022-12-31 $796,476 101,333